Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer

OBJECTIVE: The purpose of this study is to review CDK 4/6 inhibitors used to treat metastatic breast cancer for patient safety, cost and utilization. By evaluating patient outcomes and payer influence, this study will provide critical information to aid prescribers in therapeutic decisions. METHODS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Drug Assess
Autors principals: Husinka, Lakyn, Koerner, Pamela H., Miller, Rick T., Trombatt, William
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7751387/
https://ncbi.nlm.nih.gov/pubmed/33414982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2020.1857103
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars